(2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98737-29-2 Darunavir Intermediate High Purity

Short Description:

Name: (2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane

(2S,3S)-3-(Boc-Amino)-1,2-Epoxy-4-Phenylbutane 

CAS: 98737-29-2

Appearance: White to Off-White Crystalline Powder

Purity: ≥99.0% (HPLC)  Chiral Impurity: ≤0.30%

Intermediate of Darunavir HIV-1 Protease Inhibitor

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name (2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane
Synonyms (2S,3S)-3-(Boc-Amino)-1,2-Epoxy-4-Phenylbutane; (2S,3S)-3-(tert-Butoxycarbonylamino)-1,2-epoxy-4-phenylbutane; Darunavir Intermediate
CAS Number 98737-29-2
CAT Number RF-PI286
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C15H21NO3
Molecular Weight 263.33
Solubility Insoluble in Water. Soluble in Methanol, Chloroform 
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White to Off-White Crystalline Powder
Identification (HPLC) The Identification is Confirmed by HPLC
Melting Point 123.0~128.0℃
Moisture (K.F) ≤0.50%
Residue on Ignition ≤0.20%
Purity / Analysis Method ≥99.0% (HPLC)
Chlorohydrin (HPLC) ≤0.20%
Chloromethyl Ketone ≤0.10%
Other Single Impurity ≤0.20%
Total Impurities ≤1.0%
Chiral Impurity ≤0.30%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Intermediate of Darunavir (CAS 206361-99-1) HIV-1 Protease Inhibitor 

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane (CAS: 98737-29-2) with high quality, an intermediate typically in the synthesis of Darunavir (CAS 206361-99-1) and Darunavir Ethanolate (CAS 635728-49-3).

Darunavir (CAS 206361-99-1) is a new kind of non peptide anti retroviral protease inhibitors in AIDS therapy. It is first developed by the Johnson pharmaceutical Iceland branch, Tibotec. It is of the highest bioavailability in the 6 protease inhibitors (saquinavir, ritonavirvir, indinavir, naphthalene nelfinavir, amprenavir and ABT378/r). It acts by blocking the formation of new and mature virus particles from the surface of the infected host cells and inhibiting the virus's protease. When the product is used for a long time, it usually can reduce the HIV virus vector in blood, increase the count of CD4 cells, reduce the chance of HIV infection, improve the quality of life and prolong life. It is suitable for adults who are infected with the HIV virus but have no effect on the use of existing antiretroviral drugs. The drug must be combined with the use of low doses of ritonavir or other antiretroviral agents, in order to improve the efficacy.  

  • Write your message here and send it to us